BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15521358)

  • 1. Signaling mechanisms of the D3 dopamine receptor.
    Ahlgren-Beckendorf JA; Levant B
    J Recept Signal Transduct Res; 2004 Aug; 24(3):117-30. PubMed ID: 15521358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells.
    Kuzhikandathil EV; Oxford GS
    J Neurosci; 1999 Mar; 19(5):1698-707. PubMed ID: 10024356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
    Van Leeuwen DH; Eisenstein J; O'Malley K; MacKenzie RG
    Mol Pharmacol; 1995 Aug; 48(2):344-51. PubMed ID: 7651368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells.
    Zaworski PG; Alberts GL; Pregenzer JF; Im WB; Slightom JL; Gill GS
    Br J Pharmacol; 1999 Nov; 128(6):1181-8. PubMed ID: 10578130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors.
    Schmieg N; Rocchi C; Romeo S; Maggio R; Millan MJ; Mannoury la Cour C
    J Neurochem; 2016 Mar; 136(5):1037-51. PubMed ID: 26685100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs.
    Obadiah J; Avidor-Reiss T; Fishburn CS; Carmon S; Bayewitch M; Vogel Z; Fuchs S; Levavi-Sivan B
    Cell Mol Neurobiol; 1999 Oct; 19(5):653-64. PubMed ID: 10384262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling of dopamine receptors to G proteins: studies with chimeric D2/D3 dopamine receptors.
    Ilani T; Fishburn CS; Levavi-Sivan B; Carmon S; Raveh L; Fuchs S
    Cell Mol Neurobiol; 2002 Feb; 22(1):47-56. PubMed ID: 12064517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor promotes uncoupling from adenylyl cyclase of the rat D2S receptor expressed in GH4C1 cells.
    Missale C; Boroni F; Sigala S; Castelletti L; Falardeau P; Dal Toso R; Caron MG; Spano P
    J Neurochem; 1994 Mar; 62(3):907-15. PubMed ID: 8113812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric D2/D3 dopamine receptor coupling to adenylyl cyclase.
    Lachowicz JE; Sibley DR
    Biochem Biophys Res Commun; 1997 Aug; 237(2):394-9. PubMed ID: 9268722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1997 Aug; 52(2):181-6. PubMed ID: 9271339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple signaling routes involved in the regulation of adenylyl cyclase and extracellular regulated kinase by dopamine D(2) and D(3) receptors.
    Jin M; Min C; Zheng M; Cho DI; Cheong SJ; Kurose H; Kim KM
    Pharmacol Res; 2013 Jan; 67(1):31-41. PubMed ID: 23059541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cells.
    McAllister G; Knowles MR; Patel S; Marwood R; Emms F; Seabrook GR; Graziano M; Borkowski D; Hey PJ; Freedman SB
    FEBS Lett; 1993 Jun; 324(1):81-6. PubMed ID: 8099332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of increased dopamine receptor signaling in food-restricted rats.
    Carr KD; Tsimberg Y; Berman Y; Yamamoto N
    Neuroscience; 2003; 119(4):1157-67. PubMed ID: 12831870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of alternative G-mediated signaling pathways at the dopamine D2 receptor by protein kinase C.
    Di Marzo V; Vial D; Sokoloff P; Schwartz JC; Piomelli D
    J Neurosci; 1993 Nov; 13(11):4846-53. PubMed ID: 7693893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
    McAllister G; Knowles MR; Ward-Booth SM; Sinclair HA; Patel S; Marwood R; Emms F; Patel S; Smith A; Seabrook GR
    J Recept Signal Transduct Res; 1995; 15(1-4):267-81. PubMed ID: 8903944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor.
    Robinson SW; Caron MG
    Mol Pharmacol; 1997 Sep; 52(3):508-14. PubMed ID: 9281614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Membrane receptors and coupling proteins in adenohypophyseal cells].
    Cussac D; Caccavelli L; Pellegrini I; Audinot V; Jaquet P; Enjalbert A
    C R Seances Soc Biol Fil; 1993; 187(1):14-23. PubMed ID: 8242419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.
    Banihashemi B; Albert PR
    Mol Endocrinol; 2002 Oct; 16(10):2393-404. PubMed ID: 12351703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and pharmacological characterization of the human D3 dopamine receptor.
    Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G
    J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
    Chio CL; Lajiness ME; Huff RM
    Mol Pharmacol; 1994 Jan; 45(1):51-60. PubMed ID: 8302280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.